+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Thrombolytic Drug Market by Types (Fibrin Specific Drugs, Nonfibrin-Specific Drugs), Category (Abbokinase, Eminase, RETAVASE), Distribution Channel - Forecast 2024-2030

  • PDF Icon

    Report

  • 196 Pages
  • March 2024
  • Region: Global
  • 360iResearch™
  • ID: 5612901
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Thrombolytic Drug Market size was estimated at USD 1.22 billion in 2023, USD 1.43 billion in 2024, and is expected to grow at a CAGR of 17.74% to reach USD 3.83 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Thrombolytic Drug Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Thrombolytic Drug Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Thrombolytic Drug Market, highlighting leading vendors and their innovative profiles. These include AstraZeneca PLC, Becton, Dickinson and Company (BD), Boehringer Ingelheim International GmbH, Boston Scientific Corporation, Chiesi Farmaceutici S.P.A., Eli Lilly and Company, Medtronic PLC, Microbix Biosystems, Inc., Pfizer, Inc., Sanofi S.A., Siemens Healthineers AG, Sigma-Aldrich Corporation, Synergy Medical Inc, Taj Pharmaceuticals Ltd., and Teleflex Incorporated.

Market Segmentation & Coverage

This research report categorizes the Thrombolytic Drug Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Types
    • Fibrin Specific Drugs
    • Nonfibrin-Specific Drugs
  • Category
    • Abbokinase
    • Eminase
    • RETAVASE
    • Streptase
    • TNKase
  • Distribution Channel
    • Electronic Pharmacy
    • Hospital Pharmacy
    • Retail Pharmacies
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

  1. What is the market size and forecast of the Thrombolytic Drug Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Thrombolytic Drug Market?
  3. What are the technology trends and regulatory frameworks in the Thrombolytic Drug Market?
  4. What is the market share of the leading vendors in the Thrombolytic Drug Market?
  5. Which modes and strategic moves are suitable for entering the Thrombolytic Drug Market?

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Thrombolytic Drug Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing patient awareness regarding fibrinolytic therapy
5.1.1.2. Surge in prevalence of kidney diseases, stroke, and hypertension
5.1.1.3. Favorable reimbursement scenario for the drugs
5.1.2. Restraints
5.1.2.1. High cost of the medicines and treatment
5.1.3. Opportunities
5.1.3.1. Technological advancements in the treatment and increasing number of retail pharmacies
5.1.3.2. Growing healthcare expenditure and rise of collaborative activities
5.1.4. Challenges
5.1.4.1. Strict drug regulatory systems
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Thrombolytic Drug Market, by Types
6.1. Introduction
6.2. Fibrin Specific Drugs
6.3. Nonfibrin-Specific Drugs
7. Thrombolytic Drug Market, by Category
7.1. Introduction
7.2. Abbokinase
7.3. Eminase
7.4. RETAVASE
7.5. Streptase
7.6. TNKase
8. Thrombolytic Drug Market, by Distribution Channel
8.1. Introduction
8.2. Electronic Pharmacy
8.3. Hospital Pharmacy
8.4. Retail Pharmacies
9. Americas Thrombolytic Drug Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Thrombolytic Drug Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Thrombolytic Drug Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player
13. Competitive Portfolio
13.1. Key Company Profiles
13.1.1. AstraZeneca PLC
13.1.2. Becton, Dickinson and Company (BD)
13.1.3. Boehringer Ingelheim International GmbH
13.1.4. Boston Scientific Corporation
13.1.5. Chiesi Farmaceutici S.P.A.
13.1.6. Eli Lilly and Company
13.1.7. Medtronic PLC
13.1.8. Microbix Biosystems, Inc.
13.1.9. Pfizer, Inc.
13.1.10. Sanofi S.A.
13.1.11. Siemens Healthineers AG
13.1.12. Sigma-Aldrich Corporation
13.1.13. Synergy Medical Inc
13.1.14. Taj Pharmaceuticals Ltd.
13.1.15. Teleflex Incorporated
13.2. Key Product Portfolio
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
List of Figures
FIGURE 1. THROMBOLYTIC DRUG MARKET RESEARCH PROCESS
FIGURE 2. THROMBOLYTIC DRUG MARKET SIZE, 2023 VS 2030
FIGURE 3. THROMBOLYTIC DRUG MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. THROMBOLYTIC DRUG MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. THROMBOLYTIC DRUG MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. THROMBOLYTIC DRUG MARKET DYNAMICS
FIGURE 7. THROMBOLYTIC DRUG MARKET SIZE, BY TYPES, 2023 VS 2030 (%)
FIGURE 8. THROMBOLYTIC DRUG MARKET SIZE, BY TYPES, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. THROMBOLYTIC DRUG MARKET SIZE, BY CATEGORY, 2023 VS 2030 (%)
FIGURE 10. THROMBOLYTIC DRUG MARKET SIZE, BY CATEGORY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. THROMBOLYTIC DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
FIGURE 12. THROMBOLYTIC DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS THROMBOLYTIC DRUG MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS THROMBOLYTIC DRUG MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES THROMBOLYTIC DRUG MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES THROMBOLYTIC DRUG MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC THROMBOLYTIC DRUG MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC THROMBOLYTIC DRUG MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA THROMBOLYTIC DRUG MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA THROMBOLYTIC DRUG MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. THROMBOLYTIC DRUG MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 22. THROMBOLYTIC DRUG MARKET SHARE, BY KEY PLAYER, 2023
List of Tables
TABLE 1. THROMBOLYTIC DRUG MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. THROMBOLYTIC DRUG MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL THROMBOLYTIC DRUG MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. THROMBOLYTIC DRUG MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
TABLE 6. THROMBOLYTIC DRUG MARKET SIZE, BY FIBRIN SPECIFIC DRUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. THROMBOLYTIC DRUG MARKET SIZE, BY NONFIBRIN-SPECIFIC DRUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. THROMBOLYTIC DRUG MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 9. THROMBOLYTIC DRUG MARKET SIZE, BY ABBOKINASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. THROMBOLYTIC DRUG MARKET SIZE, BY EMINASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. THROMBOLYTIC DRUG MARKET SIZE, BY RETAVASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. THROMBOLYTIC DRUG MARKET SIZE, BY STREPTASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. THROMBOLYTIC DRUG MARKET SIZE, BY TNKASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. THROMBOLYTIC DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 15. THROMBOLYTIC DRUG MARKET SIZE, BY ELECTRONIC PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. THROMBOLYTIC DRUG MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. THROMBOLYTIC DRUG MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. AMERICAS THROMBOLYTIC DRUG MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
TABLE 19. AMERICAS THROMBOLYTIC DRUG MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 20. AMERICAS THROMBOLYTIC DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 21. AMERICAS THROMBOLYTIC DRUG MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 22. ARGENTINA THROMBOLYTIC DRUG MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
TABLE 23. ARGENTINA THROMBOLYTIC DRUG MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 24. ARGENTINA THROMBOLYTIC DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 25. BRAZIL THROMBOLYTIC DRUG MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
TABLE 26. BRAZIL THROMBOLYTIC DRUG MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 27. BRAZIL THROMBOLYTIC DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 28. CANADA THROMBOLYTIC DRUG MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
TABLE 29. CANADA THROMBOLYTIC DRUG MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 30. CANADA THROMBOLYTIC DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 31. MEXICO THROMBOLYTIC DRUG MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
TABLE 32. MEXICO THROMBOLYTIC DRUG MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 33. MEXICO THROMBOLYTIC DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 34. UNITED STATES THROMBOLYTIC DRUG MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
TABLE 35. UNITED STATES THROMBOLYTIC DRUG MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 36. UNITED STATES THROMBOLYTIC DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 37. UNITED STATES THROMBOLYTIC DRUG MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 38. ASIA-PACIFIC THROMBOLYTIC DRUG MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
TABLE 39. ASIA-PACIFIC THROMBOLYTIC DRUG MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 40. ASIA-PACIFIC THROMBOLYTIC DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 41. ASIA-PACIFIC THROMBOLYTIC DRUG MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 42. AUSTRALIA THROMBOLYTIC DRUG MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
TABLE 43. AUSTRALIA THROMBOLYTIC DRUG MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 44. AUSTRALIA THROMBOLYTIC DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 45. CHINA THROMBOLYTIC DRUG MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
TABLE 46. CHINA THROMBOLYTIC DRUG MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 47. CHINA THROMBOLYTIC DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 48. INDIA THROMBOLYTIC DRUG MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
TABLE 49. INDIA THROMBOLYTIC DRUG MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 50. INDIA THROMBOLYTIC DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 51. INDONESIA THROMBOLYTIC DRUG MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
TABLE 52. INDONESIA THROMBOLYTIC DRUG MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 53. INDONESIA THROMBOLYTIC DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 54. JAPAN THROMBOLYTIC DRUG MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
TABLE 55. JAPAN THROMBOLYTIC DRUG MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 56. JAPAN THROMBOLYTIC DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 57. MALAYSIA THROMBOLYTIC DRUG MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
TABLE 58. MALAYSIA THROMBOLYTIC DRUG MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 59. MALAYSIA THROMBOLYTIC DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 60. PHILIPPINES THROMBOLYTIC DRUG MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
TABLE 61. PHILIPPINES THROMBOLYTIC DRUG MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 62. PHILIPPINES THROMBOLYTIC DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 63. SINGAPORE THROMBOLYTIC DRUG MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
TABLE 64. SINGAPORE THROMBOLYTIC DRUG MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 65. SINGAPORE THROMBOLYTIC DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 66. SOUTH KOREA THROMBOLYTIC DRUG MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
TABLE 67. SOUTH KOREA THROMBOLYTIC DRUG MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 68. SOUTH KOREA THROMBOLYTIC DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 69. TAIWAN THROMBOLYTIC DRUG MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
TABLE 70. TAIWAN THROMBOLYTIC DRUG MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 71. TAIWAN THROMBOLYTIC DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 72. THAILAND THROMBOLYTIC DRUG MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
TABLE 73. THAILAND THROMBOLYTIC DRUG MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 74. THAILAND THROMBOLYTIC DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 75. VIETNAM THROMBOLYTIC DRUG MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
TABLE 76. VIETNAM THROMBOLYTIC DRUG MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 77. VIETNAM THROMBOLYTIC DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 78. EUROPE, MIDDLE EAST & AFRICA THROMBOLYTIC DRUG MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
TABLE 79. EUROPE, MIDDLE EAST & AFRICA THROMBOLYTIC DRUG MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 80. EUROPE, MIDDLE EAST & AFRICA THROMBOLYTIC DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 81. EUROPE, MIDDLE EAST & AFRICA THROMBOLYTIC DRUG MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 82. DENMARK THROMBOLYTIC DRUG MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
TABLE 83. DENMARK THROMBOLYTIC DRUG MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 84. DENMARK THROMBOLYTIC DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 85. EGYPT THROMBOLYTIC DRUG MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
TABLE 86. EGYPT THROMBOLYTIC DRUG MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 87. EGYPT THROMBOLYTIC DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 88. FINLAND THROMBOLYTIC DRUG MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
TABLE 89. FINLAND THROMBOLYTIC DRUG MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 90. FINLAND THROMBOLYTIC DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 91. FRANCE THROMBOLYTIC DRUG MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
TABLE 92. FRANCE THROMBOLYTIC DRUG MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 93. FRANCE THROMBOLYTIC DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 94. GERMANY THROMBOLYTIC DRUG MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
TABLE 95. GERMANY THROMBOLYTIC DRUG MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 96. GERMANY THROMBOLYTIC DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 97. ISRAEL THROMBOLYTIC DRUG MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
TABLE 98. ISRAEL THROMBOLYTIC DRUG MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 99. ISRAEL THROMBOLYTIC DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 100. ITALY THROMBOLYTIC DRUG MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
TABLE 101. ITALY THROMBOLYTIC DRUG MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 102. ITALY THROMBOLYTIC DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 103. NETHERLANDS THROMBOLYTIC DRUG MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
TABLE 104. NETHERLANDS THROMBOLYTIC DRUG MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 105. NETHERLANDS THROMBOLYTIC DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 106. NIGERIA THROMBOLYTIC DRUG MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
TABLE 107. NIGERIA THROMBOLYTIC DRUG MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 108. NIGERIA THROMBOLYTIC DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 109. NORWAY THROMBOLYTIC DRUG MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
TABLE 110. NORWAY THROMBOLYTIC DRUG MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 111. NORWAY THROMBOLYTIC DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 112. POLAND THROMBOLYTIC DRUG MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
TABLE 113. POLAND THROMBOLYTIC DRUG MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 114. POLAND THROMBOLYTIC DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 115. QATAR THROMBOLYTIC DRUG MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
TABLE 116. QATAR THROMBOLYTIC DRUG MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 117. QATAR THROMBOLYTIC DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 118. RUSSIA THROMBOLYTIC DRUG MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
TABLE 119. RUSSIA THROMBOLYTIC DRUG MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 120. RUSSIA THROMBOLYTIC DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 121. SAUDI ARABIA THROMBOLYTIC DRUG MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
TABLE 122. SAUDI ARABIA THROMBOLYTIC DRUG MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 123. SAUDI ARABIA THROMBOLYTIC DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 124. SOUTH AFRICA THROMBOLYTIC DRUG MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
TABLE 125. SOUTH AFRICA THROMBOLYTIC DRUG MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 126. SOUTH AFRICA THROMBOLYTIC DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 127. SPAIN THROMBOLYTIC DRUG MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
TABLE 128. SPAIN THROMBOLYTIC DRUG MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 129. SPAIN THROMBOLYTIC DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 130. SWEDEN THROMBOLYTIC DRUG MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
TABLE 131. SWEDEN THROMBOLYTIC DRUG MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 132. SWEDEN THROMBOLYTIC DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 133. SWITZERLAND THROMBOLYTIC DRUG MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
TABLE 134. SWITZERLAND THROMBOLYTIC DRUG MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 135. SWITZERLAND THROMBOLYTIC DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 136. TURKEY THROMBOLYTIC DRUG MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
TABLE 137. TURKEY THROMBOLYTIC DRUG MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 138. TURKEY THROMBOLYTIC DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 139. UNITED ARAB EMIRATES THROMBOLYTIC DRUG MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
TABLE 140. UNITED ARAB EMIRATES THROMBOLYTIC DRUG MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 141. UNITED ARAB EMIRATES THROMBOLYTIC DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 142. UNITED KINGDOM THROMBOLYTIC DRUG MARKET SIZE, BY TYPES, 2018-2030 (USD MILLION)
TABLE 143. UNITED KINGDOM THROMBOLYTIC DRUG MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 144. UNITED KINGDOM THROMBOLYTIC DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 145. THROMBOLYTIC DRUG MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 146. THROMBOLYTIC DRUG MARKET SHARE, BY KEY PLAYER, 2023
TABLE 147. THROMBOLYTIC DRUG MARKET LICENSE & PRICING

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • AstraZeneca PLC
  • Becton, Dickinson and Company (BD)
  • Boehringer Ingelheim International GmbH
  • Boston Scientific Corporation
  • Chiesi Farmaceutici S.P.A.
  • Eli Lilly and Company
  • Medtronic PLC
  • Microbix Biosystems, Inc.
  • Pfizer, Inc.
  • Sanofi S.A.
  • Siemens Healthineers AG
  • Sigma-Aldrich Corporation
  • Synergy Medical Inc
  • Taj Pharmaceuticals Ltd.
  • Teleflex Incorporated

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages196
PublishedMarch 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 1.43 Billion
Forecasted Market Value ( USD ) by 2030 $ 3.83 Billion
Compound Annual Growth Rate17.7%
Regions CoveredGlobal

Related Topics

Related Reports

Medicinal Chemistry of Drugs Affecting Cardiovascular and Endocrine Systems - Product Image

Medicinal Chemistry of Drugs Affecting Cardiovascular and Endocrine Systems

  • Book
Ischemic Stroke Market Report and Forecast 2024-2032 - Product Image

Ischemic Stroke Market Report and Forecast 2024-2032

  • Report
  • 160 Pages
  • Global
From
Acute Ischemic Stroke - Pipeline Insight, 2024 - Product Image

Acute Ischemic Stroke - Pipeline Insight, 2024

  • Clinical Trials
  • 80 Pages
  • Global
From
Thrombosis Drugs - Global Strategic Business Report - Product Image

Thrombosis Drugs - Global Strategic Business Report

  • Report
  • 387 Pages
  • Global
From
Myocardial Infarction Global Market Report 2024 - Product Image

Myocardial Infarction Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From

About the Thrombolytics Market

Thrombolytics are a class of cardiovascular drugs used to treat acute ischemic stroke, myocardial infarction, and pulmonary embolism. They work by breaking down the clot that is blocking the blood vessel, allowing blood to flow freely. Thrombolytics are typically administered intravenously, and can be used in combination with other treatments such as anticoagulants and antiplatelet drugs. The most commonly used thrombolytic is tissue plasminogen activator (tPA), which is a recombinant form of the naturally occurring enzyme plasminogen. The thrombolytics market is highly competitive, with a number of companies offering products for the treatment of cardiovascular diseases. Some of the major players in the market include Boehringer Ingelheim, Pfizer, Sanofi, Bristol-Myers Squibb, and Merck. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.